Jim Simons Cardiol Therapeutics Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.47 - $0.81 $4,747 - $8,181	10,100 New	10,100 $5,000
Q1 2022 May 13, 2022	SELL	$1.25 - $2.31 $116,250 - $214,830	-93,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.83 - $4.86 $94,977 - $252,234	-51,900 Reduced 35.82%	93,000 $171,000
Q3 2021 Nov 12, 2021	BUY	$2.03 - $4.8 $294,147 - $695,520	144,900 New	144,900 $598,000

5.07M

5.2K

9.5K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $79.9M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.